BLEOMYCIN Safety Questions, BLEOMYCIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about BLEOMYCIN. Our extensive database of BLEOMYCIN adverse events and BLEOMYCIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about BLEOMYCIN
BLEOMYCIN Safety Reports
Total BLEOMYCIN reports: 94.BLEOMYCIN FDA safety alerts: No.
Reported deaths: 20 Reported hospitalizations: 26.
Take BLEOMYCIN Side Effects Survey or Share Your BLEOMYCIN Story. BLEOMYCIN Usage.
Showing 1-75 of 94 Next >
Health Professional from JAPAN reported BLEOMYCIN problem on Nov 15, 2006. Male patient, 70 years of age, was diagnosed with penis carcinoma and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with METHOTREXATE, BRIPLATIN, LASIX, PRIMPERAN, LACTEC, GLUCOSE, ASCORBIC ACID. Patient died on 05/09/1986.BLEOMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2006. Female patient, weighting 173.3 lb, was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, caecitis, colitis, ejection fraction decreased, hypotension, ill-defined disorder, neutropenia, pleural effusion. BLEOMYCIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported BLEOMYCIN problem on July 09, 2007. Male patient, 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism. BLEOMYCIN dosage: unknown. During the same period patient was treated with PARAPLATIN, VEPESID, RANDA, KYTRIL, MEYLON, DIAMOX, DIPRIVAN. Patient died on 06/01/2006.
BLEOMYCIN problem was reported by a Pharmacist from UNITED STATES on July 13, 2007. Female patient, 62 years of age, was diagnosed with cervix carcinoma and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, constipation, hydronephrosis, oliguria, pain, pancytopenia. BLEOMYCIN dosage: unknown. During the same period patient was treated with PLATINUM. Patient died.
Health Professional from JAPAN reported BLEOMYCIN problem on July 23, 2007. Male patient, 40 years of age, was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: ulcer. BLEOMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.
BLEOMYCIN problem was reported by a Consumer or non-health professional from JAPAN on July 31, 2007. Male patient, 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DEXAMETHASONE. Patient recovered.
Health Professional from JAPAN reported BLEOMYCIN problem on Aug 02, 2007. Male patient, 29 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DEXAMETHASONE, PREDNISOLONE. Patient recovered.
BLEOMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2007. Male patient, 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: groin pain, osteonecrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DEXAMETHASONE. Patient recovered.
Pharmacist from UNITED STATES reported BLEOMYCIN problem on Aug 03, 2007. Female patient, 75 years of age, weighting 172.0 lb, was diagnosed with hodgkin's disease and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: pulmonary toxicity, syncope. BLEOMYCIN dosage: unknown. During the same period patient was treated with LANTUS, ASPIRIN, CLONIDINE, CHLORPROPAMIDE, PRILOSEC, ZOLOFT, METFORMIN. Patient died on 07/09/2007.
BLEOMYCIN problem was reported by a Pharmacist from UNITED STATES on Aug 03, 2007. Male patient, 60 years of age, was diagnosed with hodgkin's disease and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, interstitial lung disease. BLEOMYCIN dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported BLEOMYCIN problem on Aug 02, 2007. Male patient, 25 years of age, was diagnosed with testis cancer and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: groin pain, osteonecrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DEXAMETHASONE. Patient recovered.
BLEOMYCIN problem was reported by a Health Professional from JAPAN on Aug 08, 2007. Male patient, 14 years of age, was diagnosed with craniopharyngioma and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: amaurosis, brain oedema, complex partial seizures, epilepsy, hemianopia. BLEOMYCIN dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported BLEOMYCIN problem on July 30, 2007. Male patient, 17 years of age, was diagnosed with bone sarcoma and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: lymphoid tissue hyperplasia, mucoepidermoid carcinoma. BLEOMYCIN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, METHOTREXATE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, DACTINOMYCIN, CYCLOPHOSPHAMIDE. Patient recovered.
BLEOMYCIN problem was reported by a Health Professional from JAPAN on Aug 10, 2007. Female patient, 31 years of age, was diagnosed with hodgkin's disease and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. BLEOMYCIN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINBLASTINE SULPHATE, DACARBAZINE. Patient recovered.
Physician from ARGENTINA reported BLEOMYCIN problem on July 30, 2007. Male patient, 40 years of age, was diagnosed with hodgkin's disease stage iv and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: bone marrow tumour cell infiltration, febrile neutropenia, hodgkin's disease mixed cellularity recurrent, hodgkin's disease mixed cellularity stage iv, leukoencephalopathy, malignant neoplasm progression, metastasis. BLEOMYCIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, CISPLATIN, CYTARABINE, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, PROCARBAZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
BLEOMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Male patient, 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: groin pain, osteonecrosis. BLEOMYCIN dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE, DEXAMETHASONE. Patient recovered.
Physician from JAPAN reported BLEOMYCIN problem on Aug 24, 2007. Female patient, 85 years of age, was diagnosed with hodgkin's disease stage iii and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pneumonia bacterial, pulmonary haemorrhage. BLEOMYCIN dosage: unknown. During the same period patient was treated with VINBLASTINE SULPHATE, ADRIAMYCIN PFS, DACARBAZINE. Patient was hospitalized. Patient died on 08/31/2006.
BLEOMYCIN problem was reported by a Health Professional from JAPAN on Sept 10, 2007. Female patient, 31 years of age, was diagnosed with hodgkin's disease and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. BLEOMYCIN dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINBLASTINE SULPHATE, DACARBAZINE. Patient recovered.
Health Professional from NETHERLANDS reported BLEOMYCIN problem on Sept 24, 2007. Male patient, 43 years of age, was diagnosed with testis cancer and was treated with BLEOMYCIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, febrile neutropenia, lung consolidation, nervousness, pleural effusion, pneumomediastinum, respiratory failure, scrotal abscess, subcutaneous emphysema. BLEOMYCIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, NEUPOGEN. Patient died.
Showing 1-75 of 94 Next >
This
drug has an active FDA Safety Alert